Level of Evidence for Labeled Dosing Recommendations in Renal Impairment

被引:0
|
作者
Gagne, Joshua J.
Khan, Nazleen F.
Raj, Tara S.
Patel, Lajja R.
Choudhry, Niteesh K.
机构
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
668
引用
收藏
页码:390 / 391
页数:2
相关论文
共 50 条
  • [21] DOSING RECOMMENDATIONS FOR CEFTAZIDIME IN PATIENTS WITH RENAL-INSUFFICIENCY
    SPENCER, GR
    HASSANI, H
    HARDING, SM
    CLINICAL RESEARCH, 1983, 31 (02): : A633 - A633
  • [22] FLUCONAZOLE DOSING IN RENAL IMPAIRMENT - A DRUG USAGE EVALUATION
    MOODY, SB
    SVESKA, KJ
    HOSPITAL FORMULARY, 1993, 28 (05): : 499 - 502
  • [23] VANCOMYCIN DOSING CHART FOR USE IN PATIENTS WITH RENAL IMPAIRMENT
    BROWN, DL
    MAURO, LS
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 11 (01) : 15 - 19
  • [24] Dosing adjustment of 10 antimicrobials for patients with renal impairment
    Preston, SL
    Briceland, LL
    Lomaestro, BM
    Lesar, TS
    Bailie, GR
    Drusano, GL
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (12) : 1202 - 1207
  • [25] Reappraisal of Linezolid Dosing in Renal Impairment To Improve Safety
    Crass, Ryan L.
    Cojutti, Pier Giorgio
    Pai, Manjunath P.
    Pea, Federico
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (08)
  • [26] New Recommendations for Use of Metformin in Renal Impairment
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1493): : 51 - 51
  • [27] Quantifying the effects of hepatic impairment on abemaciclib exposure to support dosing recommendations
    van Beek, S. W.
    Turner, P. K.
    Van der Walt, J. S.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E126 - E126
  • [28] Effect of renal disease and hemodialysis on foscarnet pharmacokinetics and dosing recommendations
    Aweeka, FT
    Jacobson, MA
    Martin-Munley, S
    Hedman, A
    Schoenfeld, P
    Omachi, R
    Tsunoda, S
    Gambertoglio, JG
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 20 (04) : 350 - 357
  • [29] PHARMACOKINETICS AND DOSING OF ANTIMICROBIAL AGENTS IN RENAL IMPAIRMENT .1.
    JACKSON, EA
    MCLEOD, DC
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1974, 31 (01): : 36 - 52
  • [30] PHARMACOKINETICS AND DOSING OF ANTIMICROBIAL AGENTS IN RENAL IMPAIRMENT .2.
    JACKSON, EA
    MCLEOD, DC
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1974, 31 (02): : 137 - 148